15 pharmaceutical projects signed landing Jiaxing, a total investment of 10 billion yuan

Recently, the Yangtze River Delta (Jiaxing Nanhu) Biopharmaceutical Industry Synergy Innovation Conference was held in Jiaxing City, Zhejiang Province.
meeting brought together experts and scholars from all over the country in the field of biopharmaceutical industry, for the development of modern pharmaceutical industry to cultivate ideas.
a total of 15 pharmaceutical projects completed electronic contracting, a total investment of 10 billion yuan.
six projects in the South Lake District, with a total investment of more than 8 billion yuan.
biopharmaceutical industry is the strategic commanding point of the new round of scientific and technological revolution and industrial revolution in the world, and it is also the main direction of China's strategic emerging industries.
According to The 2019 China Biopharmaceutical Industry Development Report, China's biopharmaceutical market has been expanding in size from 2015 to 2019, with annual market growth of about 11% outstrending the world.
data show that China's biopharmaceutical market will grow from more than 370 billion yuan in 2019 to nearly 400 billion yuan in 2020.
the next five years (2020-2025) China's biopharmaceutical industry market size will continue to maintain a growth rate of 10%-15%, by 2025 the market size will exceed 500 billion yuan.
, China's biopharmaceutical industry has broad prospects.
a long time, Jiaxing attaches great importance to the development of the biopharmaceutical industry, specifically introduced Jiaxing new manufacturing "555" action, clearly as Jiaxing focus on the cultivation and development of one of the strategic emerging industries.
years of cultivation, has gathered to Yunding Xinyao, Jiaxin, Arthur, and agents as the representative of the key enterprises.
same time, Jiaxing investment environment is good, the cumulative actual use of foreign capital of more than 38 billion U.S. dollars, there are 70 world's top 500 enterprises in Jiaxing investment in 109 industrial projects.
in Jiaxing City, the life and health industry is an important part of the "1341" modern industrial system in the South Lake District.
At present, the life and health industry in the region has begun to take shape, bringing together more than 100 enterprises in the fields of biotechnology, medical devices, medical testing, big data analysis centers, scientific research institutions and platforms, including more than 10 national high-tech enterprises in the field of life and health, such as Tag Medical.
, it is understood that at the beginning of this year, the South Lake District has 10 billion biopharmaceutical projects landed.
February 21, the company signed a contract for the development and industrialization of high-end drug research and development and industrialization of Arthur Pharmaceuticals with a total investment of 10.58 billion yuan.
The project will co-introduce a number of well-known enterprises at home and abroad to set up a cooperative body, the construction of China's headquarters and major production bases, focusing on high-end drugs, innovative drugs, such as research and development, production and sales, to build a foothold in China's multinational pharmaceutical companies.
project will be located in Jiaxing Science and Technology City, the total planning land of about 156 acres, in two phases of construction, including high-end pharmaceutical production base and multi-functional production platform and other ten projects.
is completed, it is expected to achieve annual operating income of 8 billion yuan, annual tax revenue of about 500 million yuan.
The South Lake District is taking the opportunity of introducing 20 billion biopharmaceutical projects as an opportunity to build the South Lake Life Health Microelectronics Industry Eco-Park located in Jiaxing Science and Technology City.
At the same time, the South Lake District will set up a 5 billion yuan scale of large-scale special health industry fund, dedicated to supporting large-scale health industry projects settled in the South Lake District, will focus on public health infectious diseases, cancer-targeted treatment of innovative drugs, immune system drugs, neuropharmaceuticals and other aspects of innovative drugs, generic drugs, high-end medical devices and large health-related areas of the project settled in the South Lake District and industrialization, and strive to build the South Lake District to grow the triangle and even the country's influential large-health industry development.